flumazenil has been researched along with gyki 52466 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hönack, D; Löscher, W | 1 |
Chapman, AG; Chimirri, A; De Sarro, A; de Sarro, G; Gitto, R; Giusti, P; Grasso, S | 1 |
2 other study(ies) available for flumazenil and gyki 52466
Article | Year |
---|---|
Effects of the non-NMDA antagonists NBQX and the 2,3-benzodiazepine GYKI 52466 on different seizure types in mice: comparison with diazepam and interactions with flumazenil.
Topics: Animals; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Diazepam; Dose-Response Relationship, Drug; Drug Interactions; Electroshock; Excitatory Amino Acid Antagonists; Flumazenil; Male; Mice; Muscle Relaxants, Central; Pentylenetetrazole; Quinoxalines; Receptors, AMPA; Reflex; Seizures; Synaptic Transmission | 1994 |
GYKI 52466 and related 2,3-benzodiazepines as anticonvulsant agents in DBA/2 mice.
Topics: Animals; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Flumazenil; Male; Mice; Mice, Inbred DBA; Pyrrolidinones; Rats; Rats, Sprague-Dawley | 1995 |